METHOD FOR PREDICTING THE DEVELOPMENT OF CARDIOTOXICITY IN PATIENTS WITH HER2 POSITIVE BREAST CANCER OF INITIALLY LOW / MODERATE CARDIOVASCULAR RISK RECEIVING A TARGETED THERAPY WITH TRASTUZUMAB AFTER ANTHRACYCLINE-CONTAINING CHEMOTHERAPY

FIELD: medicine.SUBSTANCE: invention refers to medicine and can be used for prediction of developing cardiotoxicity in HER2 patients with positive breast cancer of initially low / moderate cardiovascular risk receiving a targeted therapy with trastuzumab after anthracycline-containing chemotherapy....

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Ovchinnikov Artem Germanovich, Filatova Anastasiya Yurevna, Ageev Fail Taipovich, Ibragimova Nursiyat Magomedalievna, Gavryushina Svetlana Valerevna, Vitsenya Marina Vyacheslavna, Potekhina Aleksandra Viktorovna, Chazova Irina Evgenevna
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	DIAGNOSIS HUMAN NECESSITIES HYGIENE IDENTIFICATION MEDICAL OR VETERINARY SCIENCE SURGERY
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!